Literature DB >> 7925817

A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.

J Thomas1, J Wang, H Takubo, J Sheng, S de Jesus, K S Bankiewicz.   

Abstract

The main focus of the present study was to define the rotational response of 6-hydroxydopamine-lesioned rats to dopaminergic agonists to separate the partially lesioned rats from those having complete substantia nigra (SN) and ventral tegmental area (VTA) lesions. Animals were challenged by amphetamine and L-DOPA for 10 consecutive weeks. There was a correlation between rotational behavior and extent of midbrain cell loss. Rats with complete SN and < 40% VTA lesion turned more than 5 times/min after amphetamine administration, but not after L-DOPA; animals with complete SN and 40-80% VTA lesions turned vigorously following amphetamine and began turning after L-DOPA administration. Rats with complete SN and VTA lesions turned less after amphetamine than the other two groups, while their turning after L-DOPA administration increased. Extracellular dopamine (DA) measured by microdialysis, intracellular DA measured by postmortem tissue punches, and tyrosine hydroxylase-immunoreactive cell count in SN and VTA were also evaluated. It appears that the dopaminergic cells in the lateral VTA affect DA concentration in the medial caudate nucleus. In the nucleus accumbens of the lesioned side, DA release and metabolism substantially increased with the larger VTA lesion. Dopamine turnover rate in the caudate was also higher in the group with < 40% VTA lesion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925817     DOI: 10.1006/exnr.1994.1054

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

1.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

2.  The role of dopamine receptors in regulating the size of axonal arbors.

Authors:  C L Parish; D I Finkelstein; J Drago; E Borrelli; M K Horne
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats.

Authors:  Tan Wang; Xuebin Cao; Tian Zhang; Qingqing Shi; Zhibin Chen; Beisha Tang
Journal:  Neurol Sci       Date:  2015-03-19       Impact factor: 3.307

4.  Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats.

Authors:  Fei Cao; Shenggang Sun; E-tang Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

5.  The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice.

Authors:  Clare L Parish; David I Finkelstein; Wanida Tripanichkul; Abhay R Satoskar; John Drago; Malcolm K Horne
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

6.  Effect of levodopa chronic administration on behavioral changes and fos expression in basal ganglia in rat model of PD.

Authors:  Yan Xu; Shenggang Sun; Xuebing Cao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

7.  Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.

Authors:  Nadja Van Camp; Ruth Vreys; Koen Van Laere; Erwin Lauwers; Dirk Beque; Marleen Verhoye; Cindy Casteels; Alfons Verbruggen; Zeger Debyser; Luc Mortelmans; Jan Sijbers; Johan Nuyts; Veerle Baekelandt; Annemie Van der Linden
Journal:  MAGMA       Date:  2010-02-19       Impact factor: 2.310

8.  The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Authors:  W Michael Panneton; V B Kumar; Qi Gan; William J Burke; James E Galvin
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

9.  Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.

Authors:  Ming Ming; Xuping Li; Xiaolan Fan; Dehua Yang; Liang Li; Sheng Chen; Qing Gu; Weidong Le
Journal:  J Transl Med       Date:  2009-06-28       Impact factor: 5.531

10.  Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease.

Authors:  Xiang-Yun Li; Guang-Hai Mei; Qiang Dong; Yu Zhang; Zhuang-Li Guo; Jing-Jing Su; Yu-Ping Tang; Xue-Hong Jin; Hou-Guang Zhou; Yan-Yan Huang
Journal:  Parkinsons Dis       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.